Investment Analysts’ Recent Ratings Changes for Waters (WAT)

A number of research firms have changed their ratings and price targets for Waters (NYSE: WAT):

• 8/12/2026 – Waters was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 8/10/2026 – Waters had its price target raised by Citigroup Inc. from $425.00 to $470.00. They now have a “buy” rating on the stock.
• 8/5/2026 – Waters was given a new $430.00 price target by Morgan Stanley.
• 8/5/2026 – Waters had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $400.00 price target on the stock.
• 8/5/2026 – Waters had its “outperform” rating reaffirmed by Evercore Inc. They now have a $420.00 price target on the stock.
• 8/5/2026 – Waters had its price target raised by Royal Bank Of Canada from $435.00 to $475.00. They now have an “outperform” rating on the stock.
• 8/5/2026 – Waters was given a new $420.00 price target by Stifel Nicolaus.
• 8/5/2026 – Waters was upgraded by TD Cowen from “hold” to “buy”. They now have a $475.00 price target on the stock, up from $408.00.
• 8/5/2026 – Waters had its price target raised by Barclays PLC from $425.00 to $460.00. They now have an “overweight” rating on the stock.
• 8/5/2026 – Waters had its price target raised by Wells Fargo & Company from $370.00 to $400.00. They now have an “equal weight” rating on the stock.
• 7/20/2026 – Waters was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/17/2026 – Waters had its “hold (c)” rating reaffirmed by Weiss Ratings.
• 7/15/2026 – Waters had its “hold” rating reaffirmed by TD Cowen.
• 7/14/2026 – Waters had its price target raised by The Goldman Sachs Group, Inc. from $380.00 to $425.00. They now have a “buy” rating on the stock.
• 7/12/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/9/2026 – Waters had its price target raised by Morgan Stanley from $350.00 to $390.00. They now have an “equal weight” rating on the stock.
• 7/8/2026 – Waters is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $435.00 price target on the stock.
• 7/8/2026 – Waters was upgraded by Royal Bank Of Canada to “moderate buy”.
• 7/8/2026 – Waters had its “buy” rating reaffirmed by Guggenheim. They now have a $440.00 price target on the stock.
• 7/6/2026 – Waters had its “outperform” rating reaffirmed by Evercore Inc. They now have a $410.00 price target on the stock.
• 6/26/2026 – Waters is now covered by Sanford C. Bernstein. They set an “outperform” rating and a $435.00 price target on the stock.
• 6/25/2026 – Waters was upgraded by Sanford C. Bernstein to “strong-buy”.

Insider Activity at Waters

In related news, Director Christopher A. Kuebler sold 3,626 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the sale, the director directly owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.31% of the stock is currently owned by insiders.

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.